Suppr超能文献

全基因组分析实验进化的假丝酵母菌揭示了多种新型多药耐药机制。

Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance.

机构信息

VIB Center for Microbiology, Leuven, Belgium.

Department of Biology, KU Leuven, Leuven, Belgium.

出版信息

mBio. 2021 Apr 5;12(2):e03333-20. doi: 10.1128/mBio.03333-20.

Abstract

is globally recognized as an opportunistic fungal pathogen of high concern, due to its extensive multidrug resistance (MDR). Still, molecular mechanisms of MDR are largely unexplored. This is the first account of genome-wide evolution of MDR in obtained through serial exposure to azoles, polyenes, and echinocandins. We show the stepwise accumulation of copy number variations and novel mutations in genes both known and unknown in antifungal drug resistance. Echinocandin resistance was accompanied by a codon deletion in hot spot 1 and a substitution in "novel" hot spot 3. Mutations in and further increased the echinocandin MIC. Decreased azole susceptibility was linked to a mutation in transcription factor and overexpression of the drug efflux pump Cdr1, a segmental duplication of chromosome 1 containing , and a whole chromosome 5 duplication, which contains The latter was associated with increased expression of , , and but not The simultaneous emergence of nonsense mutations in and was shown to decrease amphotericin B susceptibility, accompanied with fluconazole cross-resistance. A mutation in , a gene mainly known for its role in DNA damage homeostasis, further increased the polyene MIC. Overall, this study shows the alarming potential for and diversity of MDR development in , even in a clade until now not associated with MDR (clade II), stressing its clinical importance and the urge for future research. is a recently discovered human fungal pathogen and has shown an alarming potential for developing multi- and pan-resistance toward all classes of antifungals most commonly used in the clinic. Currently, has been globally recognized as a nosocomial pathogen of high concern due to this evolutionary potential. So far, this is the first study in which the stepwise progression of multidrug resistance (MDR) in is monitored Multiple novel mutations in known resistance genes and genes previously not or vaguely associated with drug resistance reveal rapid MDR evolution in a clade II isolate. Additionally, this study shows that experimental evolution can be a powerful tool to discover new drug resistance mechanisms, although it has its limitations.

摘要

是一种被广泛认为具有高威胁性的机会性真菌病原体,因为它具有广泛的多药耐药性(MDR)。然而,MDR 的分子机制在很大程度上仍未被探索。这是首次通过对唑类、多烯类和棘白菌素类药物进行连续暴露,在 中全基因组范围内研究 MDR 进化的报道。我们展示了在已知和未知的抗真菌药物耐药性基因中,数量变异和新突变的逐步积累。棘白菌素类耐药性伴随着 1 号热点区的密码子缺失和“新”热点区 3 中的取代。 和 中的突变进一步增加了棘白菌素的 MIC。唑类药物敏感性降低与转录因子 的突变和药物外排泵 Cdr1 的过度表达有关,该泵包含染色体 1 的一个片段重复,以及一个包含 的整条染色体 5 重复,后者与 、 和 的表达增加有关,但与 无关。同时出现 和 中的无义突变,导致两性霉素 B 敏感性降低,同时伴有氟康唑交叉耐药。一个主要因其在 DNA 损伤稳态中的作用而闻名的基因 中的突变进一步增加了多烯类的 MIC。总的来说,这项研究表明,即使在一个迄今为止与 MDR 无关的进化枝(II 进化枝)中, 中 MDR 的发展具有惊人的潜力和多样性,这突显了其临床重要性和未来研究的紧迫性。是一种最近发现的人类真菌病原体,对所有临床上常用的抗真菌药物类别都表现出惊人的多药和泛耐药潜力。目前,由于这种进化潜力, 已被全球公认为一种高关注的医院获得性病原体。到目前为止,这是首次在 中监测多药耐药性(MDR)逐步进展的研究。在已知耐药基因和以前未或模糊与耐药性相关的基因中发现的多个新突变,揭示了 II 进化枝中 的快速 MDR 进化。此外,这项研究表明,尽管实验进化有其局限性,但它可以成为发现新耐药机制的有力工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f29/8092288/34b264f24a6e/mBio.03333-20_f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验